Journal of Commercial Biotechnology,volume 10,issue 1  (09-2011)

Period of time： 2011年1期

Publisher： Palgrave Macmillan Ltd

Founded in： 1994

Total resources： 35

ISSN： 1478-565X

Subject： Q81 Bioengineering ( Biotechnology )

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Journal of Commercial Biotechnology,volume 10,issue 1

Menu

Editorial: Creating a competitive European life science sector

By Fisken Jane in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 1-4

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

Financing papers: The role of the European Commission in fostering innovation in the life sciences and biotechnology

By Kütt Waldemar in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 6-14

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

Commercial biotechnology in Germany: An overview

By Bialojan Siegfried in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 15-21

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

What will it take to get institutional investors interested in life sciences again?

By Brooks William in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 22-28

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

Consolidation challenges in Europe's life science sector – Making it happen

By Stoiber Wolfgang in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 29-34

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

Riposte: FDA response to ‘Yin, yang and the biopharmaceutical industry’

By Rosenberg Amy S in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 36-39

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

The Sarbanes–Oxley Act and non-US issuers: Considerations for international companies

By Gates Megan N in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 40-53

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

Biotechnology and pharmaceutical R&D and licensing trends: You pays your money and takes your chances

By Ratliff Alan in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 54-59

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

The impact of pharmacogenetics and pharmacogenomics

By Lindpaintner Klaus in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 60-77

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

A new model to evaluate the market for biotechnology

By McMurray Amanda in (2003)

Journal of Commercial Biotechnology,volume 10,issue 1 , Vol. 10, Iss. 1, 2003-09 , pp. 78-84

Palgrave Macmillan Ltd

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 15 item(s)